查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493210

週邊血管裝置市場規模、佔有率、趨勢分析報告：按類型、地區、細分市場預測，2024-2030 年

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

週邊血管裝置市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球週邊血管器械市場規模將達到148.39億美元，2024年至2030年複合年成長率為6.1%。

推動市場成長的主要因素之一是靜脈疾病或慢性靜脈功能不全（CVI）盛行率的上升。老年人口的增加、微創血管內手術需求的增加、新產品的推出以及主要市場參與企業為擴大業務而進行的合併和聯盟也是推動市場成長的一些因素。

IVC過濾器、血流動力學調節裝置、EVAR血管支架、血管造影術導管和流行調節裝置是周邊血管內手術、冠狀動脈手術以及周邊動脈疾病和冠狀動脈疾病治療中使用的一些設備。這些儀器在手術過程中使用，以最大限度地減少對患者的干擾。對治療血管疾病的微創手術的需求不斷成長，對周圍血管裝置的市場需求產生了顯著影響。患者往往更喜歡微創手術，因為它可以加速或幫助癒合過程，減少對患者的創傷，並縮短住院時間。

例如，2020 年 2 月，為大鳳凰城地區 160 萬居民提供服務的矽谷首屈一指的醫療保健提供者 Honor Health 宣布，其心血管卓越中心因周邊動脈疾病(PAD) 獲得認可。周邊動脈疾病是一種常見的心血管疾病，在美國影響超過 1000 萬人。作為 DETOUR II 臨床試驗的一部分，一名股動脈完全閉塞的患者接受了手術。治療方法是經皮（皮膚穿刺）搭橋手術。多達 200 名患者參與了這項研究，該研究可能會核准美國 的食品藥物管理局。對晚期 PAD 患者進行了腿部無切口的經皮經皮手術。因此，與傳統方法相比，此類手術侵入性較小，並可能帶來更高的風險。在DETOUR II治療中，透過血管支架繞過股動脈受損部分，基本上提供了一條旁路，讓血液再次自由流向患者的小腿。

此外，微創手術往往可以最大限度地減少術後併發症並降低死亡率。其中一些手術，例如球囊血管成形術、藥物釋放型技術、動脈粥狀硬化斑塊切除術和雷射消熔，對於改善生活品質非常重要。因此，這些優勢預計將增加週邊血管裝置的市場需求。

患者意識的提高和醫療保健支出的提高，以及對微創手術的接受度的提高，都有助於擴大市場佔有率。此外，整個行業預計將受益於醫療保健基礎設施的快速擴張和新興地區醫療保健支出的增加。此外，主要企業推出的新穎產品正在推動市場發展。例如，2022年1月，庫克醫療的新型膝下藥物釋放型支架（BTK）被美國食品藥物管理局（FDA）授予突破性器材分類。這項創新旨在治療危及四肢的持續缺血患者。

週邊血管器械市場報告亮點

  • 按類型分類，外周支架細分市場佔據最大的市場佔有率，2023年銷售佔有率為26.0%。這是由於支架技術的改進和微創手術的採用增加。
  • 按類型分類，外圍配件領域預計在預測期內將以最快的複合年成長率成長。這是因為市場上有許多周邊配件供應商，而印度和中國等新興國家正在以低成本供應這些產品。除此之外，由於術後風險和併發症較少，對球囊血管成形術中使用的球囊充氣裝置的需求正在增加，這進一步推動了市場的成長。
  • 北美在2023年佔據市場主導地位，銷售佔有率為39.52%。該市場受到心血管疾病盛行率上升和老年人口成長等因素的推動。
  • 預計亞太地區在預測期內的複合年成長率將是最快的。這是由於公眾對該地區快速診斷和治療需求的認知不斷提高，以及週邊血管和心臟病學技術的進步。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章週邊血管器械市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 週邊血管器械市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章週邊血管器械市場：類型估計與趨勢分析

  • 週邊血管器械市場：類型儀表板
  • 週邊血管器械市場：類型變化分析
  • 2018-2030 年按類型分類的周邊血管器械市場規模、預測與趨勢分析
  • 外周支架
  • PTA球囊
  • 導管
  • 血管內動脈瘤修補血管支架
  • 斑塊矯正裝置
  • 周邊設備配件
  • 下腔靜脈濾器
  • 血流動力學血流調節器

第5章週邊血管裝置市場：按國家和類型分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Abbott
    • Edward Lifesciences Corporation
    • Medtronic
    • Teleflex Incorporated
    • Boston Scientific Corporation
    • WL Gore &Associates, Inc.
    • Boston Scientific Corporation
    • Cook Group Inc.
    • Covidien
Product Code: 978-1-68038-237-2

Peripheral Vascular Devices Market Growth & Trends:

The global peripheral vascular devices market size is expected to reach USD 14,839.0 million by 2030 and is projected to grow at a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the main factors propelling the market growth is the rising prevalence of venous disorders or Chronic Venous Insufficiency (CVI). Its adoption is also being accelerated by the growing elderly population and the rising demand for minimally invasive endovascular operations, novel product launch, mergers, and collaborations by the key market players for business expansion are some of the factors that boosts the market growth.

IVC filters, hemodynamic flow alteration, EVAR stent-grafts, angiography catheters, and plague modification devices are some of the devices utilized in peripheral endovascular and coronary procedures, as well as for treating peripheral arterial or coronary arterial disease. These tools are used during surgery to reduce patient interference with the least amount of disruption. The market demand for peripheral vascular devices is significantly influenced by the rising need for less invasive procedures for the treatment of vascular disease. Patients are more likely to prefer minimally invasive procedures since they speed up or aid the healing process, lessen patient trauma, and necessitate shorter hospital stays.

For instance, in February 2020, HonorHealth, a premier healthcare provider in the Valley that provides care to 1.6 million residents of the greater Phoenix area, announced today that its Cardiovascular Center of Excellence has made a significant advancement in the treatment of peripheral arterial disease (PAD). It is a common cardiovascular condition that affects more than 10 million people in the country. A patient with a completely blocked femoral artery underwent surgery as part of a DETOUR II clinical trial. The treatment was a percutaneous (skin puncture) bypass. Up to 200 patients were accepted for the research, which might result in FDA approval for the treatment. Without cutting open or making incisions in the leg, a peripheral percutaneous bypass procedure was conducted on a patient with advanced PAD. This makes such surgery minimal invasive and possibly riskier than the conventional approach. The DETOUR II treatment involved the use of stent grafts that run via the femoral vein, bypassing the damaged section of the femoral artery and, in essence, providing a bypass so that blood can flow freely to the patient's lower limb once more.

Moreover, minimally invasive procedures tend to minimize the post-surgery complications and reduce the mortality rates. Some of these procedures including balloon angioplasty, drug-eluting technologies, excisional atherectomy or laser ablation are significant in improving quality of life. As a result, these advantages are anticipated to raise market demand for peripheral vascular devices.

Increased patient awareness and healthcare spending, as well as higher acceptance rates of minimally invasive surgery, all contribute to its significant market share. In addition, the industry as a whole is anticipated to benefit from the rapid expansion of healthcare infrastructure and rising healthcare spending in emerging regions. Moreover, novel product launches by the key players boost the market. For instance, in January 2022, a new drug-eluting stent for below the knee (BTK) manufactured by Cook Medical was given Breakthrough Device classification by the US Food and Drug Administration (FDA). This innovation is meant to treat patients with persistent ischemia that poses a hazard to their limbs.

Peripheral Vascular Devices Market Report Highlights:

  • Based on type, the peripheral stents segment held the market with the largest revenue share of 26.0% in 2023, owing to the improvements in stent technology and the rising adoption of less invasive procedures
  • Based on type, the peripheral accessories segment is anticipated to grow at the fastest CAGR over the forecast period. This is due to the presence of larger number of suppliers of peripheral accessories in the market as well as developing countries such as India and China offering low-cost supplies for these products. In addition to this, there is increasing demand for balloon inflation devices used for balloon angioplasty owing to the less risk and complications post-surgery, which is further driving the market growth
  • North America dominated the market with the revenue share of 39.52% in 2023. The market is driven by factors like the rising prevalence of cardiovascular disorders and the growing elderly population
  • Asia Pacific is anticipated to witness at the fastest CAGR over the forecast period. This is due to the increased public awareness of the need for prompt diagnosis and treatment, as well as improvements in peripheral vascular and cardiology technology in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Parent market analysis (Model 2)
    • 1.7.4. Approach 2: Parent market analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Peripheral Vascular Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of PAD
      • 3.2.1.2. Increasing clinical trials and studies
      • 3.2.1.3. Novel product launch
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment and device
      • 3.2.2.2. Product recalls
  • 3.3. Peripheral Vascular Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Vascular Devices Market: Type Estimates & Trend Analysis

  • 4.1. Peripheral Vascular Devices Market: Type Dashboard
  • 4.2. Peripheral Vascular Devices Market: Type Movement Analysis
  • 4.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Peripheral Stents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1. Iliac Artery Stents
      • 4.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Femoral Artery Stents
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Carotid Artery Stents
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Renal Artery Stents
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Other Peripheral Stents
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. PTA Balloons
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Catheters
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.1.1. Angiography Catheters
      • 4.6.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.1.2. Guiding Catheters
      • 4.6.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.1.3. IVUS/OCT Catheters
      • 4.6.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Endovascular Aneurysm Repair Stent Grafts
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.7.1.1. Thoracic Endovascular Aneurysm Stent Grafts
      • 4.7.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.7.1.2. Abdominal Endovascular Aneurysm Stent Grafts
      • 4.7.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Plaque Modification Devices
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.8.1.1. Atherectomy Devices
      • 4.8.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.8.1.2. Thrombectomy Devices
      • 4.8.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Peripheral Accessories
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.1. Guidewires
      • 4.9.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.2. Peripheral Vascular Closure Devices
      • 4.9.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.3. Balloon Inflation Devices
      • 4.9.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.4. Introducer Sheaths
      • 4.9.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Inferior Vena Cava Filters
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Hemodynamic Flow Alteration Devices
    • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Peripheral Vascular Devices Market: Regional Estimates & Trend Analysis by Country, Type

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework/ reimbursement structure
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2023
    • 6.3.4. Abbott
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Edward Lifesciences Corporation
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Medtronic
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Teleflex Incorporated
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Boston Scientific Corporation
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. W. L. Gore & Associates, Inc.
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Boston Scientific Corporation
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Cook Group Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Covidien
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Volume Price Analysis
  • Fig. 8 Peripheral Vascular Devices market snapshot (2023)
  • Fig. 9 Peripheral Vascular Devices market segmentation
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Peripheral Vascular Devices market: Type movement analysis
  • Fig. 15 Peripheral Vascular Devices market: Type outlook and key takeaways
  • Fig. 16 Peripheral Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 17 Iliac Artery Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 18 Femoral Artery Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 19 Carotid Artery Stentsmarket size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 20 Renal Artery Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 21 Other Peripheral Stentsmarket size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 22 PTA Balloons market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 23 Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 24 Angiography Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 25 Guiding Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 26 IVUS/OCT Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 27 Endovascular Aneurysm Repair Stent Grafts market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 28 Thoracic Endovascular Aneurysm Stent Grafts market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 29 Abdominal Endovascular Aneurysm Stent Grafts market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 30 Plaque Modification Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 31 Atherectomy Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 32 Thrombectomy Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 33 Peripheral Accessories market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 34 Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 35 Peripheral Vascular Closure Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 36 Balloon Inflation Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 37 Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 38 Frontline Finesse Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 39 Extra Support Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 40 Workhorse Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 41 Specialty Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 42 Inferior Vena Cava Filters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 43 Permanent Filters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 44 Retrievable Filters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 45 Hemodynamic Flow Alteration Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 46 Chronic Total Occlusion Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 47 Embolic Protection Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 48 Peripheral Vascular Devices market, by region, 2018 - 2030 (USD Million)
  • Fig. 49 North America market, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 51 Canada market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market, 2018 - 2030 (USD Million)
  • Fig. 53 UK market, 2018 - 2030 (USD Million)
  • Fig. 54 Germany market, 2018 - 2030 (USD Million)
  • Fig. 55 France market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy market, 2018 - 2030 (USD Million)
  • Fig. 57 Spain market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 59 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 60 Norway market, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 62 China market, 2018 - 2030 (USD Million)
  • Fig. 63 India market, 2018 - 2030 (USD Million)
  • Fig. 64 Japan market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia market, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait market, 2018 - 2030 (USD Million)